1.河南省人民医院/河南大学人民医院心血管内科 河南 郑州 450003
1.阜外华中心血管病医院,心血管内科,河南 郑州 451464
2.阜外华中心血管病医院,检验科,河南 郑州 451464
王明明,男,1998—,医学硕士生,主要从事心肌炎及心力衰竭左室重构机制究,E⁃mail:w1710191115@163.com
刘洪智,男,1973—,医学博士,主任医师,主要从事冠心病介入治疗及心肌炎、心力衰竭左室重构机制研究,E⁃mail:13073713520@163.com
收稿:2024-11-26,
纸质出版:2025-06-25
移动端阅览
王明明,王蕴安,李豪等.程序性细胞死亡蛋白⁃1单抗对自身免疫性心肌炎小鼠心肌重构的影响[J].武汉大学学报(医学版),2025,46(06):709-715.
WANG Mingming,WANG Yun'an,LI Hao,et al.Effect of programed cell death protein⁃1 monoclonal antibody on cardiac remodeling in mice with autoimmune myocarditis[J].Medical Journal of Wuhan University,2025,46(06):709-715.
王明明,王蕴安,李豪等.程序性细胞死亡蛋白⁃1单抗对自身免疫性心肌炎小鼠心肌重构的影响[J].武汉大学学报(医学版),2025,46(06):709-715. DOI: 10.14188/j.1671-8852.2024.0908.
WANG Mingming,WANG Yun'an,LI Hao,et al.Effect of programed cell death protein⁃1 monoclonal antibody on cardiac remodeling in mice with autoimmune myocarditis[J].Medical Journal of Wuhan University,2025,46(06):709-715. DOI: 10.14188/j.1671-8852.2024.0908.
目的
2
探讨程序性细胞死亡蛋白⁃1(PD⁃1)单抗对肌球蛋白诱导的实验性自身免疫性心肌炎(EAM)小鼠左室心肌炎症、心肌纤维化及心功能的影响,建立免疫检查点抑制剂(ICI)相关心肌炎小鼠模型。
方法
2
选择7周龄雄性BALB/c小鼠18只,随机分为正常对照组、EAM组及EAM+PD⁃1单抗组,在第0天及第7天,除正常对照组外,余实验组小鼠用100 μg充分乳化后的小鼠重链肌球蛋白(Myhc⁃α)皮下多点免疫;从第8天开始EAM组按每次5 mg·kg
-1
给予同种型IgG腹腔注射,EAM+PD⁃1单抗组按每次5 mg·kg
-1
给予PD⁃1单抗腹腔注射,每3 d给药一次,共5次。第21天行心脏超声检查、ELISA法检测外周血cTnI、INF⁃γ及TNF⁃α水平,HE染色及免疫组化检测心肌病理改变及炎性细胞浸润情况,Masson染色检测心肌纤维化。
结果
2
与正常对照组小鼠相比,EAM组小鼠左心室射血分数(LVEF)降低、左心室收缩末期内径(LVESD)增加;与EAM组相比,EAM+PD⁃1单抗组小鼠LVEF下降及LVESD增加更显著(均
P
<
0.05)。HE染色及免疫组化染色结果显示EAM组可见多种炎细胞浸润,且EAM+PD⁃1单抗组小鼠炎症更加明显。Masson染色显示
EAM组小鼠左室心肌间质胶原纤维明显增多;与EAM组相比,EAM+PD⁃1单抗组小鼠左室心肌胶原纤维增多、胶原容积分数升高更为显著(均
P
<
0.05)。ELISA检测结果显示,与对照组相比,EAM组小鼠外周血中cTnI、TNF⁃α和IFN⁃γ均升高,且EAM+PD⁃1单抗组小鼠上述指标升高最为显著(均
P
<
0.05)。
结论
2
在小鼠Myhc⁃α两次免疫基础上,联用多次PD⁃1单抗腹腔注射可加重EAM小鼠心肌炎性细胞浸润、心肌损伤、心肌纤维化及心功能下降,成功建立了ICI相关心肌炎小鼠模型。
Objective
2
To investigate the effects of programmed cell death protein⁃1 (PD⁃1) monoclonal antibody on left ventricular myocardial inflammation
myocardial fibrosis
and cardiac function in myosin⁃induced autoimmune myocarditis mice
and to establish a murine model of immune checkpoint inhibitor (ICI)⁃associated myocarditis.
Methods
2
Eighteen male BALB/c mice were randomly divided into three groups: normal control group
experimental autoimmune myocarditis (EAM) group
and EAM+PD⁃1 inhibitor group. Mice in the EAM and EAM+PD⁃1 inhibitor groups received subcutaneous immunization with 100 μg mouse heavy chain myosin (Myhc⁃α) emulsified with complete Freund's adjuvant at a 1∶1 ratio on days 0 and 7. From day 8
the EAM group was administered isotype IgG intraperitoneally at 5 mg·kg
-1
per dose
and the EAM+PD⁃1 inhibitor group received PD⁃1 inhibitor at 5 mg·kg
-1
per dose intraperitoneally every three days
for a total of five doses. After 21 days of treatment
echocardiography was performed
and ELISA was used to measure circulating cardiac injury markers (cTnI) and inflammatory cytokines (IFN⁃γ and TNF⁃α) levels. Left ventricular myocardium was evaluated for pathological changes and inflammatory cell infiltration using HE staining and immunohistochemistry. Myocardial fibrosis was assessed via Masson staining.
Results
2
Compared to the control group
EAM mice showed significantly reduced LVEF and increased LVESD. The reduction in LVEF was even more pronounced in the EAM+PD⁃1 inhibitor group than in the EAM group
with a more sign
ificant increase in LVESD. HE staining and immunohistochemistry staining revealed inflammatory cell infiltration in the EAM group
which was more severe in the EAM+PD⁃1 inhibitor group. Masson staining demonstrated a substantial increase in myocardial collagen fibers in the EAM group
with elevated collagen volume fraction
which was further exacerbated in the EAM+PD⁃1 inhibitor group than in the EAM group. ELISA results indicated elevated peripheral blood levels of cTnI
TNF⁃α
and IFN⁃γ in EAM mice compared to controls
with the highest levels observed in the EAM+PD⁃1 inhibitor group (
P
<
0.05).
Conclusion
2
In the mice with Myhc⁃α⁃induced myocarditis
combined with multiple intraperitoneal injections of PD⁃1 monoclonal antibody
the myocardial inflammatory cell infiltration
myocardial injury
myocardial fibrosis
and decline in cardiac function were exacerbated. This experiment successfully established a mouse model of ICI⁃associated myocarditis.
MUNIR A Z , GUTIERREZ A , QIN J , et al . Immune‑checkpoint inhibitor‑mediated myocarditis: CTLA4, PD1 and LAG3 in the heart [J ] . Nat Rev Cancer , 2024 , 24 ( 8 ): 540 ‑ 553 .
SUIJKERBUIJK K P M , VAN EIJS M J M , VAN WIJK F , et al . Clinical and translational attributes of immune‑related adverse events [J ] . Nat Cancer , 2024 , 5 ( 4 ): 557 ‑ 571 .
MICHEL L , HELFRICH I , HENDGEN‑COTTA U B , et al . Targeting early stages of cardiotoxicity from anti‑PD1 immune checkpoint inhibitor therapy [J ] . Eur Heart J , 2022 , 43 ( 4 ): 316 ‑ 329 .
TARRIO M L , GRABIE N , BU D X , et al . PD‑1 protects against inflammation and myocyte damage in T cell‑mediated myocarditis [J ] . J Immunol , 2012 , 188 ( 10 ): 4876 ‑ 4884 .
GRABIE N , GOTSMAN I , DACOSTA R , et al . Endothelial programmed death‑1 ligand 1 (PD‑L1) regulates CD8 + T‑cell mediated injury in the heart [J ] . Circulation , 2007 , 116 ( 18 ): 2062 ‑ 2071 .
SEKO Y , YAGITA H , OKUMURA K , et al . Roles of programmed death‑1 (PD‑1)/PD‑1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3 [J ] . Cardiovasc Res , 2007 , 75 ( 1 ): 158 ‑ 167 .
TSURUOKA K , WAKABAYASHI S , MORIHARA H , et al . Exacerbation of autoimmune myocarditis by an immune checkpoint inhibitor is dependent on its time of administration in mice [J ] . Int J Cardiol , 2020 , 313 : 67 ‑ 75 .
ZHU H , GALDOS F X , LEE D , et al . Identification of pathogenic immune cell subsets associated with checkpoint inhibitor‑induced myocarditis [J ] . Circulation , 2022 , 146 ( 4 ): 316 ‑ 335 .
MA P , LIU J , QIN J , et al . Expansion of pathogenic cardiac macrophages in immune checkpoint inhibitor myocarditis [J ] . Circulation , 2024 , 149 ( 1 ): 48 ‑ 66 .
AXELROD M L , MEIJERS W C , SCREEVER E M , et al . T cells specific for α‑myosin drive immunotherapy‑related myocarditis [J ] . Nature , 2022 , 611 ( 7937 ): 818 ‑ 826 .
WON T , KALINOSKI H M , WOOD M K , et al . Cardiac myosin‑specific autoimmune T cells contribute to immune‑checkpoint‑inhibitor‑associated myocarditis [J ] . Cell Rep , 2022 , 41 ( 6 ): 111611 .
0
浏览量
247
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621